Carl Zeiss Meditec AG (ETR:AFX)
Germany · Delayed Price · Currency is EUR 30.44
+0.62 (2.08%)
Aug 13, 2026, 5:35 PM CET
Carl Zeiss Meditec AG Income Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 2,181 | 2,228 | 2,066 | 2,089 | 1,903 | 1,647 | |
Revenue Growth | 0.07% | 7.82% | -1.11% | 9.80% | 15.55% | 23.31% |
Cost of Revenue | 1,057 | 1,052 | 977.5 | 883.54 | 775.24 | 679.57 |
Gross Profit | 1,124 | 1,175 | 1,089 | 1,206 | 1,128 | 967.21 |
Selling, General & Admin | 634.43 | 626.52 | 569.21 | 504.06 | 438.06 | 363.98 |
Research & Development | 335.51 | 326.28 | 343.09 | 349.28 | 291.37 | 232.07 |
Other Operating Expenses | -3.32 | -0.92 | -18.12 | 4.31 | 1.29 | -2.45 |
Total Operating Expenses | 966.62 | 951.88 | 894.18 | 857.64 | 730.72 | 593.6 |
Operating Income | 157.63 | 223.32 | 194.45 | 348.12 | 396.88 | 373.61 |
Interest Income | 5.14 | 6.57 | 22.4 | 28.11 | 13.25 | 1.56 |
Interest Expense | -24.39 | -26.6 | -29.42 | -15.25 | -9.1 | -8.58 |
Other Non-Operating Income (Expense) | 18.47 | -9.4 | 53.44 | 51.58 | 2.46 | -27.55 |
Total Non-Operating Income (Expense) | -0.79 | -29.43 | 46.41 | 64.44 | 6.61 | -34.56 |
Pretax Income | 156.74 | 193.89 | 240.87 | 412.56 | 403.49 | 339.05 |
Provision for Income Taxes | 36.41 | 51.55 | 60.71 | 120.56 | 107.58 | 101.53 |
Net Income | 120.33 | 142.35 | 180.15 | 292.01 | 295.91 | 237.52 |
Minority Interest in Earnings | -1.18 | 1.14 | 1.43 | 1.61 | 2 | 1.24 |
Net Income to Common | 121.51 | 141.21 | 178.73 | 290.4 | 293.91 | 236.28 |
Net Income Growth | -19.06% | -20.99% | -38.45% | -1.20% | 24.39% | 93.06% |
Shares Outstanding (Basic) | 88 | 88 | 89 | 89 | 89 | 89 |
Shares Outstanding (Diluted) | 88 | 88 | 89 | 89 | 89 | 89 |
Shares Change | 0.37% | -1.48% | -0.66% | - | - | - |
EPS (Basic) | 1.38 | 1.61 | 2.01 | 3.25 | 3.29 | 2.64 |
EPS (Diluted) | 1.38 | 1.61 | 2.01 | 3.25 | 3.29 | 2.64 |
EPS Growth | -19.30% | -19.90% | -38.15% | -1.22% | 24.62% | 92.70% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | - | 170.46 | 160.51 | 185.21 | 145.4 | 332.54 |
Free Cash Flow Growth | - | 6.21% | -13.34% | 27.38% | -56.28% | 122.88% |
Free Cash Flow Per Share | - | 1.95 | 1.81 | 2.07 | 1.63 | 3.72 |
Dividends Per Share | 0.550 | 0.550 | 0.600 | 1.100 | 1.100 | 0.900 |
Dividend Growth | -8.33% | -8.33% | -45.45% | 0% | 22.22% | 80.00% |
Gross Margin | 51.55% | 52.76% | 52.69% | 57.71% | 59.26% | 58.73% |
Operating Margin | 7.23% | 10.02% | 9.41% | 16.66% | 20.86% | 22.69% |
Profit Margin | 5.52% | 6.39% | 8.72% | 13.98% | 15.55% | 14.42% |
FCF Margin | - | 7.65% | 7.77% | 8.86% | 7.64% | 20.19% |
EBITDA | 157.63 | 349.7 | 327.22 | 422.19 | 466.65 | 435.2 |
EBITDA Margin | 7.23% | 15.70% | 15.84% | 20.21% | 24.52% | 26.43% |
EBIT | 157.63 | 223.32 | 194.45 | 348.12 | 396.88 | 373.61 |
EBIT Margin | 7.23% | 10.02% | 9.41% | 16.66% | 20.86% | 22.69% |
Effective Tax Rate | 23.23% | 26.59% | 25.21% | 29.22% | 26.66% | 29.95% |